Breaking Corporate Events, Analysed in Real Time

Zydus Lifesciences Launches REVAHALE, India's First Once-Daily Nebulised LAMA for COPD

Zydus Lifesciences has introduced REVAHALE, the first once-daily nebulised Long-Acting Muscarinic Antagonist (LAMA) in India for COPD maintenance. This launch addresses a critical gap for patients who struggle with handheld inhalers, offering sustained 24-hour bronchodilation.

Zydus Lifesciences and Apollo Hospitals Partner to Launch Shield Multi-Cancer Detection Test

Zydus Lifesciences has entered into a Memorandum of Understanding with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection (MCD) test in India. This partnership utilizes Zydus's exclusive agreement with Guardant Health to provide a non-invasive, blood-based screening tool for 10 common cancer types.